|
|
||||||||
Veterans Administration Hospital and University of Washington Medical School, Seattle, Washington
Correspondence: For reprints contact: Steven Larson, Nuclear Medicine Section (115), Veterans Administration Hospital, 4435 Beacon Ave. So., Seattle, WA 98108.
ABSTRACT
The EMT-6 sarcoma-like tumor of BALB/c mice can be grown as a solid subcutaneous transplantable tumor in vivo or as a monolayer culture in vitro. We have studied the uptake of gallium-67 by this tumor growing subcutaneously on the backs of 6-week-old BALB/c mice. After i.v. administration of Ga-67 citrate, tumor uptakes were as high as any others reported for mouse tumors. Also, for unknown reasons, there was appreciable reduction in tumor uptake with increasing amounts of Ga-67 citrate, even in the microcurie range. Furthermore, when mouse serum is prelabeled with Ga-67 and then injected, the EMT-6 uptake is greater than with Ga-67 administered as citrate (p < 0.02). We believe that the finding of avid Ga-67 uptake in vivo helps to establish this unique in vivo/in vitro tumor system as a valid experimental model for studies regarding the mechanism of Ga-67 accumulation by neoplastic tissue.
This article has been cited by other articles:
![]() |
A. L. Vavere and M. J. Welch Preparation, Biodistribution, and Small Animal PET of 45Ti-Transferrin J. Nucl. Med., April 1, 2005; 46(4): 683 - 690. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |